Skip to main content

Table 4 In patients subgrouped by different treatment regimens, no differences in lipid metabolism parameters were demonstrated, even under zinc monotherapy.

From: Alterations of lipid metabolism in Wilson disease

 

n

Limits of normal

DPA

Trientine

Zinc

Combination

p-value

ALT

249

f: -35 U/l

m: -50 U/l

36

(8-3743)

30

(10-398)

34.5

(14-162)

34

(12-100)

0.133

AST

250

f: -35 U/l

m: -50 U/l

28

(11-2106)

27

(12-167)

25

(10-110)

24

(12-79)

0.775

Bilirubin

239

< 1.0 mg/dl

0.7

(0,3-23)

0.6

(0.2-4.5)

0.6

(0.2-10)

0.8

(0.3-1.8)

0.306

Albumin

231

30-50 g/l

44.2

(28-54)

43

(21-55)

46

(24-73)

44.4

(30-56)

0.033

TG

247

< 150 mg/dl

106

(24-888)

97

(29-287)

94

(12-438)

87

(44-178)

0.505

Cholesterol

248

< 200 mg/dl

179

(90-288)

185.5

(107-365)

187

(122-340)

172

(137-259)

0.780

HDL

124

f: >50 mg/dl m: >40 mg/dl

56

(27-103)

59.5

(39-113)

54

(39-100)

48.5

(32-90)

0.467

LDL

115

< 160 mg/dl

102.5

(43-204)

98

(52-218)

113

(51-229)

94.5

(64-151)

0.324

BMI

166

18.5-25 kg/m²

23.7

(18.1-33.7)

22.5

(14.2-41.1)

21.9

(15.1-34.1)

25.2

(18.5-29)

0.060